Gary Schwitzer from the Health News Review questions STAT news’ decision to accept a sponsorship deal from PhRMA. “As highly as I think of STAT’s journalism, if it depends even in part on PhRMA sponsorship, I would rather see them ratchet back and decline such deals. Certainly PhRMA is thrilled with STAT saying ‘Yes’ – allowing them to buy their way into regular appearances in the STAT newsletter. This is a foot in the door for an industry to buy juxtaposition to messages that often call their practices into question.”
